U.S. Markets closed

Celyad Oncology SA (CYAD)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
3.5500-0.3900 (-9.90%)
At close: 04:00PM EST
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.32
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 38.5700
52 Week Low 33.5000
50-Day Moving Average 34.0104
200-Day Moving Average 34.7219

Share Statistics

Avg Vol (3 month) 3988.37k
Avg Vol (10 day) 317.08k
Shares Outstanding 522.59M
Implied Shares Outstanding 6N/A
Float 87.79M
% Held by Insiders 10.07%
% Held by Institutions 11.25%
Shares Short (Dec 30, 2021) 418.64k
Short Ratio (Dec 30, 2021) 40.01
Short % of Float (Dec 30, 2021) 4N/A
Short % of Shares Outstanding (Dec 30, 2021) 40.08%
Shares Short (prior month Nov 29, 2021) 45.99k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in EUR.

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Sep 29, 2021


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)5k
Net Income Avi to Common (ttm)-17.42M
Diluted EPS (ttm)-1.3410
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)6.1M
Total Cash Per Share (mrq)0.39
Total Debt (mrq)2.87M
Total Debt/Equity (mrq)15.06
Current Ratio (mrq)0.97
Book Value Per Share (mrq)1.22

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A